Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction

Cardiovascular Research

Volumn 77, Issue 4, 2008, Pages 713-721

  Tsutsumi, Takaki ^a   Ide, Tomomi ^a   Yamato, Mayumi ^b   Kudou, Wataru ^b   Andou, Makoto ^a   Hirooka, Yoshitaka ^a   Utsumi, Hideo ^c   Tsutsui, Hiroyuki ^d   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholine; Autonomic nervous system; Heart failure; Oxidative stress

Indexed keywords

ACETYLCHOLINE; ATROPINE; BETA ADRENERGIC RECEPTOR; FREE RADICAL; MUSCARINIC RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; TEMPOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; ELECTRON SPIN RESONANCE; EXPERIMENTAL STUDY; HEART ATRIUM PACING; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE OXYGEN CONSUMPTION; IN VIVO STUDY; MECHANICAL PROBE; MODULATION; MOUSE; NEWBORN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; VAGUS NERVE STIMULATION;

ANIMALS; CARDIAC PACING, ARTIFICIAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME INHIBITORS; HEART; HEART FAILURE; MALE; MICE; MUSCARINIC ANTAGONISTS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA; SULFHYDRYL COMPOUNDS; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE;

EID: 39749170512     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm092     Document Type: Article

References (38)

1. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
2. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993;22:72A-84A.
3. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
4. McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993;14:1493-1498.
5. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 2000;86:152-157.
6. Murdoch CE, Zhang M, Cave AC, Shah AM. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 2006;71:208-215.
7. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 1997;100:1813-1821.
8. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998;98:1329-1334.
9. Luo J, Xuan YT, Gu Y, Prabhu SD. Prolonged oxidative stress inverts the cardiac force-frequency relation: role of altered calcium handling and myofilament calcium responsiveness. J Mol Cell Cardiol 2006;40:64-75.
10. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001;89:279-286.
11. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004;109:544-549.
12. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004;109:120-124.
13. Nakayama Y, Miyano H, Shishido T, Inagaki M, Kawada T, Sugimachi M et al. Heart rate-independent vagal effect on end-systolic elastance of the canine left ventricle under various levels of sympathetic tone. Circulation 2001;104:2277-2279.
14. Azevedo ER, Parker JD. Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure. Circulation 1999;100:274-279.
15. Levy MN, Blattberg B. Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 1976;38:81-84.
16. Newton GE, Parker AB, Landzberg JS, Colucci WS, Parker JD. Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle. J Clin Invest 1996;98:2756-2763.
17. Zweier JL, Kuppusamy P. Electron paramagnetic resonance measurements of free radicals in the intact beating heart: a technique for detection and characterization of free radicals in whole biological tissues. Proc Natl Acad Sci USA 1988;85:5703-5707.
18. Utsumi H, Muto E, Masuda S, Hamada A. In vivo ESR measurement of free radicals in whole mice. Biochem Biophys Res Commun 1990;172:1342- 1348.
19. Yamato M, Egashira T, Utsumi H. Application of in vivo ESR spectroscopy to measurement of cerebrovascular ROS generation in stroke. Free Radic Biol Med 2003;35:1619-1631.
20. Sano H, Matsumoto K, Utsumi H. Synthesis and imaging of blood-brain-barrier permeable nitroxyl-probes for free radical reactions in brain of living mice. Biochem Mol Biol Int 1997;42:641-647.
21. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T et al. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2003;107:1418-1423.
22. Keston AS, Brandt R. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal Biochem 1965;11:1-5.
23. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991;68:1471-1481.
24. Ando M, Katare RG, Kakinuma Y, Zhang D, Yamasaki F, Muramoto K et al. Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 2005;112:164-170.
25. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-2420.
26. Khaper N, Singal PK. Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol 2001;37:1461-1466.
27. Mann DL, Kent RL, Parsons B, Cooper Gt. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.
28. Dhein S, van Koppen CJ, Brodde OE. Muscarinic receptors in the mammalian heart. Pharmacol Res 2001;44:161-182.
29. Akiyama T, Yamazaki T, Ninomiya I. In vivo detection of endogenous acetylcholine release in cat ventricles. Am J Physiol 1994;266:H854-H860.
30. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 2005;115:509-517.
31. Dedkova EN, Ji X, Wang YG, Blatter LA, Lipsius SL. Signaling mechanisms that mediate nitric oxide production induced by acetylcholine exposure and withdrawal in cat atrial myocytes. Circ Res 2003;93:1233-1240.
32. Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 2001;3:203-213.
33. Mohan RM, Heaton DA, Danson EJ, Krishnan SP, Cai S, Channon KM et al. Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function. Circ Res 2002;91:1089-1091.
34. Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002; 40:477-484.
35. Nediani C, Borchi E, Giordano C, Baruzzo S, Ponziani V, Sebastiani M et al. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. J Mol Cell Cardiol 2007;42:826-834.
36. Shinyashiki M, Pan CJ, Lopez BE, Fukuto JM. Inhibition of the yeast metal reductase heme protein fre1 by nitric oxide (NO): a model for inhibition of NADPH oxidase by NO. Free Radic Biol Med 2004;37:713-723.
37. Matsuura W, Sugimachi M, Kawada T, Sato T, Shishido T, Miyano H et al. Vagal stimulation decreases left ventricular contractility mainly through negative chronotropic effect. Am J Physiol 1997;273:H534- H539.
38. Mark AL. Sensitization of cardiac vagal afferent reflexes at the sensory receptor level: an overview. Fed Proc 1987;46:36-40.